Among these strategies, targeting stromal desmoplasia (e.g., alleviating ECM deposition) and restoring tumour immunosurveillance (e.g., promoting CD8+ T-cell infiltration and function) have attracted much attention from researchers. The gene discussed is CD8A; the disease is neoplasm.